Screening and Surveillance of Gastrointestinal and Pancreatic Cancers

Dear Colleagues,

Screening in average- and high-risk populations has become one of the most important cornerstones in current gastroenterology practice. Recommendations and guidelines for the subsequent surveillance of individuals who have been diagnosed with a GI/pancreatic precancerous condition have been developed.

The aim of high-quality screening and surveillance is clear: to enable an early intervention (either by endoscopy or other means) to allow the best possible outcome for the patient.

Our Special Issue is focused on screening in average- and high-risk populations and on appropriate surveillance.

We especially welcome the following types of papers:

• Randomised controlled trials;
• Prospective studies;
• Review articles supported by the most recent literature.

We would appreciate if gastroenterologists involved in screening programmes contributed to this Special Issue.

Potential topics of interest include, but are not limited to, the following:

• Oesophageal neoplasia—current screening and surveillance of Barrett’s oesophagus;
• Gastric neoplasia—screening and surveillance of high-risk populations;
• Coeliac disease—screening and surveillance;
• Small bowel polyposis—screening and surveillance;
• Pancreatic precancerous lesions—surveillance;
• Colorectal neoplasia—screening in average- and high-risk populations and surveillance.

Prof. Dr. Darina Kohoutová
Prof. Dr. Jan Bures
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.